Transient Tachypnoea of the Newborn (TTN)

1. Clinical Overview

Transient tachypnoea of the newborn (TTN) is a common, self-limiting respiratory disorder caused by delayed clearance of fetal lung fluid after birth. [1,2] It typically presents within the first few hours of life with tachypnoea and mild respiratory distress, resolving within 24-72 hours with supportive care alone. [1,3]

Key Facts

Clinical Pearls

Pearl 1: TTN is a DIAGNOSIS OF EXCLUSION. You must consider and rule out neonatal sepsis and respiratory distress syndrome (RDS) before confidently diagnosing TTN.

Pearl 2: The "squeeze" theory - during vaginal delivery, thoracic compression during passage through the birth canal expels lung fluid. Caesarean section bypasses this, increasing TTN risk.

Pearl 3: The 60/60 rule - if respiratory rate exceeds 60/min, the infant should be nil by mouth and fed via NG tube to prevent aspiration. Start feeds when RR consistently below 60.

Pearl 4: If symptoms persist beyond 24-48 hours, reconsider the diagnosis. Think: infection, congenital heart disease, surfactant deficiency, or persistent pulmonary hypertension.

Pearl 5: Elective C-section at less than 39 weeks significantly increases TTN risk. This is why NICE recommends elective C-sections should not be performed before 39 weeks unless medically indicated.

---

2. Epidemiology

Incidence

Demographics and Risk Factors

---

3. Pathophysiology

Stepwise Mechanism

Step 1: Fetal Lung Fluid Production

• During fetal life, lungs are filled with approximately 20-30 mL/kg of lung fluid
• This fluid is actively secreted by alveolar type II epithelial cells
• Chloride secretion through apical CFTR channels drives fluid into airways (outward direction)
• Fetal lung fluid production rate: approximately 4-6 mL/kg/hour [1,10]
• Lung fluid is essential for normal lung development, expansion, and alveolar differentiation
• Fluid volume increases throughout gestation, peaking at term

Step 2: Transition at Birth (Normal)

• Labour triggers massive catecholamine surge (adrenaline/noradrenaline levels increase 10-20 fold) [1,10]
• Catecholamines bind to β-adrenergic receptors on alveolar epithelial cells
• This activates epithelial sodium channels (ENaC) - primarily α, β, and γ subunits [10,17]
• ENaC activation reverses the direction of fluid movement: secretion → absorption
• Sodium is actively absorbed from alveolar lumen into epithelium
• Water follows sodium osmotically (driven by Na+/K+-ATPase basolateral pump)
• Fluid moves from alveoli → pulmonary interstitium → lymphatics and pulmonary capillaries [1,10]
• Thoracic compression during vaginal delivery mechanically expels ~30-35 mL of fluid from airways
• First breaths create negative intra-thoracic pressure, drawing fluid into interstitium
• Normal transition clears approximately 90% of lung fluid within first hours of life [10]

Step 3: Failure of Fluid Clearance (TTN)

• Elective caesarean section without labour: No catecholamine surge → minimal ENaC activation [1,2,10]
• Reduced ENaC expression/function: Late preterm infants have lower ENaC expression [17]
• Absent thoracic compression: No mechanical expulsion of fluid
• Delayed switch from secretion to absorption: Chloride secretion continues longer than normal
• Impaired lymphatic drainage: Overwhelmed by excess fluid volume
• Result: Lung fluid persists in alveoli, interstitium, and peribronchial spaces
• Radiographic manifestation: Fluid tracking along bronchovascular bundles and fissures [1,3]

Step 4: Clinical Consequence

• Retained fluid in airspaces → reduced functional residual capacity (FRC)
• Air trapping around fluid-filled regions → hyperinflation on chest X-ray
• Decreased lung compliance → increased work of breathing → recession and tachypnoea
• Ventilation-perfusion (V/Q) mismatch → mild-moderate hypoxia
• Tachypnoea is compensatory mechanism to maintain minute ventilation despite reduced tidal volume
• Grunting (if present) attempts to maintain positive end-expiratory pressure (auto-PEEP)
• Infant appears "wet" on CXR with prominent perihilar markings and fluid in fissures [3,8]

Step 5: Resolution

• Over 24-72 hours, lung fluid is gradually absorbed via:
  • Pulmonary lymphatics (primary route - accounts for ~60% of clearance)
  • Pulmonary capillaries (secondary route - ~40% of clearance)
• ENaC expression increases with postnatal age even without labour [10,17]
• Postnatal catecholamine and cortisol levels rise, enhancing absorption
• Tachypnoea and oxygen requirement gradually diminish as fluid clears
• Full radiographic and clinical recovery expected by 72 hours [1,2]
• No long-term pulmonary sequelae in isolated TTN [2,13]

Molecular Mechanisms

Exam Detail: Advanced Pathophysiology - Exam Viva Points:

Fetal-to-Neonatal Fluid Switch:

• Before labour: Chloride secretion (CFTR-mediated) drives fluid OUT into alveolar lumen
• During labour: ENaC activation drives sodium (and water) IN from alveolar lumen to interstitium
• This represents a fundamental shift from lung as secretory organ to absorptive organ

Why Does Labour Protect?

1. Catecholamine surge: Plasma adrenaline increases 10-20 fold during active labour [1,10]
2. Glucocorticoid release: Endogenous cortisol surge enhances ENaC expression
3. Mechanical compression: Thoracic squeeze expels ~30 mL of fluid via airway
4. Vasopressin release: Augments fluid clearance via vascular route

Why Are Late Preterm Infants at Risk?

• ENaC subunit expression is gestation-dependent - peaks at 38-40 weeks [17]
• At 34-36 weeks, ENaC density is 30-50% lower than term
• Na+/K+-ATPase activity is also reduced in late preterm
• This explains why TTN risk is 4-5 fold higher at 36 weeks vs 40 weeks [7,13]

Genetic Factors:

• Polymorphisms in ENaC genes (SCNN1A, SCNN1B, SCNN1G) may increase TTN susceptibility
• β-adrenergic receptor polymorphisms also implicated in delayed clearance
• No routine genetic testing currently recommended

Role of Surfactant:

• TTN was traditionally thought to be purely a fluid clearance problem
• Emerging evidence suggests surfactant dysfunction may contribute [9,13]
• Some TTN infants have reduced surfactant protein levels
• However, exogenous surfactant is NOT indicated for isolated TTN [13,21]

---

4. Clinical Presentation

Typical Presentation

Symptom Severity Classification

Timeline

Differential Diagnoses (CRITICAL)

Red Flags Requiring Urgent Reassessment

---

5. Clinical Examination

Structured Neonatal Examination

General Inspection

• Alert or lethargic (lethargic → sepsis concern)
• Colour: pink, acrocyanosis (normal), central cyanosis (concern)
• Activity and tone

Respiratory Assessment

Silverman-Andersen Score (Respiratory Distress Severity)

Score interpretation: 0-3 = mild; 4-6 = moderate; 7-10 = severe

Cardiovascular

• Heart sounds (murmur?)
• Femoral pulses (present and equal?)
• Apex beat (displaced?)
• Hepatomegaly (heart failure?)

Other Systems

• Abdomen: scaphoid (diaphragmatic hernia?)
• Temperature: fever or hypothermia (sepsis?)
• Tone and activity

---

6. Investigations

First-Line Investigations

Chest X-Ray Features

Classic TTN Radiographic Triad: [1,3,8,22]

1. Hyperinflation (most common finding - present in 85-95% of cases)
2. Fluid in horizontal fissure (pathognomonic - present in 60-80%)
3. Perihilar streaking/prominent vascular markings (present in 70-90%)

CXR Comparison: TTN vs RDS vs Pneumonia

Exam Detail: Radiology Exam Pearls:

Fluid in Horizontal Fissure:

• Appears as a thin horizontal radiodense line in right mid-zone
• Located at level of 4th rib anteriorly
• Represents fluid tracking along fissure between right upper and middle lobes
• Virtually pathognomonic for TTN (95% specificity) [3,8]
• Disappears within 24-48 hours as fluid clears

Perihilar "Streakiness":

• Also called "sunburst pattern" or "shaggy heart borders"
• Represents interstitial oedema in peribronchial and perivascular spaces
• Radiates outward from hila toward periphery
• More prominent than normal neonatal vascular markings

Why Hyperinflation?

• Air trapping occurs around fluid-filled alveoli and small airways
• Infant tries to maintain FRC by increasing end-expiratory lung volume
• Results in flattened diaphragms and increased rib spaces
• This is OPPOSITE to RDS, which shows low lung volumes (atelectasis)

Serial Imaging:

• Repeat CXR at 24-48 hours if symptoms persist [1,8]
• Rapid improvement (50% cleared by 24h, 90% by 48h) supports TTN diagnosis
• Worsening or static CXR → reconsider diagnosis (RDS, pneumonia, CHD)

Lung Ultrasound (Emerging Modality)

Advantages over Chest X-Ray: [9,15,16,22]

• No ionising radiation (critical in newborns)
• Point-of-care bedside assessment
• Can be performed serially without radiation exposure
• Higher sensitivity than CXR for pleural fluid (97% vs 67%)
• Real-time dynamic assessment of lung sliding
• Accuracy for TTN diagnosis: Sensitivity 96-98%, Specificity 93-97% [9,15]

TTN-Specific Lung Ultrasound Findings: [9,15,16]

Lung Ultrasound Score (LUS): [16]

• Each hemithorax divided into 6 zones (12 total zones)
• Each zone scored 0-3 based on B-line density
• Score 0: Normal A-lines, less than 3 B-lines
• Score 1: ≥3 well-spaced B-lines
• Score 2: Coalescent B-lines ("white lung")
• Score 3: Consolidation (tissue-like appearance)
• TTN typically scores 12-24 (moderate severity)
• LUS more than 24 suggests RDS or severe TTN requiring CPAP [16]

Serial Lung Ultrasound for Prognosis: [16,20]

• Repeat LUS at 6-12 hours predicts need for CPAP (sensitivity 89%)
• Improving LUS score (decrease ≥6 points) predicts resolution within 24h
• Static or worsening LUS → escalate respiratory support [16,20]

Clinical Application:

• Diagnosis: Differentiate TTN from RDS (TTN: double lung point; RDS: uniform white lung)
• Monitoring: Serial LUS to track fluid clearance (avoid repeated CXR)
• Prognosis: Predict duration of oxygen requirement and need for CPAP [9,15,16,20]
• Limitation: Operator-dependent; requires training; not yet standard of care everywhere

Clinical Pearl: Imaging Strategy in Suspected TTN:

Initial Assessment:

• CXR remains gold standard for initial diagnosis [1,8,22]
• Look for hyperinflation + fissure fluid + perihilar streaking
• If lung ultrasound available and trained operator: can use as first-line to avoid radiation [9,15]

Follow-Up:

• If improving clinically (RR decreasing, less O2): NO repeat imaging needed
• If NOT improving by 24 hours: Repeat CXR or lung ultrasound
• If deteriorating: Urgent repeat CXR to exclude pneumothorax, RDS, CHD [1,8]

Remember: TTN is a clinical and radiographic diagnosis of exclusion - imaging confirms but does NOT replace clinical assessment

Laboratory Investigations

Sepsis Workup (MANDATORY in all suspected TTN): [1,13,21]

Important: CRP at admission is often normal in early-onset sepsis; repeat at 24 hours [1,13,21]

Other Investigations (As Indicated):

When to Consider Echocardiography

Exam Detail: Advanced Investigation Interpretation for Vivas:

Blood Gas Patterns:

• TTN: pH 7.30-7.35, pCO2 45-55, pO2 60-80, HCO3 normal, lactate normal
• RDS: pH 7.20-7.30, pCO2 more than 55 (progressive), pO2 less than 60, respiratory acidosis
• Sepsis: pH less than 7.25, lactate more than 4, mixed metabolic and respiratory acidosis
• PPHN: pH normal/alkalotic, pO2 less than 50 despite high FiO2, hyperventilation

FBC Patterns Suggesting Sepsis (NOT TTN):

• WCC less than 5 or more than 25 × 10⁹/L
• Absolute neutrophil count less than 5 × 10⁹/L (neutropenia is highly concerning)
• I:T ratio (immature:total neutrophils) more than 0.2
• Thrombocytopenia (platelets less than 100) - late sign

CRP Kinetics:

• CRP at 0 hours: Often normal even in sepsis (too early to rise)
• CRP at 24 hours: Rises in sepsis; most sensitive time point [13,21]
• CRP more than 10 mg/L at 24 h: High suspicion for infection - continue antibiotics
• CRP less than 5 mg/L at 24-48h + negative cultures: Safe to stop antibiotics [13,21]

When to Perform Lumbar Puncture:

• Not routinely indicated in suspected TTN
• Consider if: Persistent fever, lethargy, seizures, CRP more than 20 mg/L, positive blood culture
• LP contraindicated if: Cardiovascular instability, respiratory failure, coagulopathy

---

7. Management

TTN is a self-limiting condition requiring supportive care only. There is no disease-specific treatment. [1,13,21] Management focuses on maintaining oxygenation, preventing aspiration, and excluding sepsis until proven otherwise.

Management Algorithm

         NEONATE WITH RESPIRATORY DISTRESS
         (Tachypnoea, Recession, Within First Hours)
                        ↓
┌─────────────────────────────────────────────────────┐
│        INITIAL STABILIZATION (ABC)                  │
│  - Warm, dry, stimulate (prevent hypothermia)       │
│  - Check airway, breathing, circulation             │
│  - Pulse oximetry (pre-ductal AND post-ductal)     │
│  - Supplemental oxygen if SpO2 less than 92%       │
│  - Assess severity: Silverman-Andersen score       │
└─────────────────────────────────────────────────────┘
                        ↓
┌─────────────────────────────────────────────────────┐
│        INVESTIGATIONS (Parallel)                    │
│  - Chest X-ray (or lung ultrasound if available)   │
│  - Blood gas (pre-feed capillary or arterial)      │
│  - Blood glucose (all distressed newborns)         │
│  - FBC, CRP, blood culture (before antibiotics)    │
│  - Pre-post ductal saturations (PPHN screening)    │
└─────────────────────────────────────────────────────┘
                        ↓
┌─────────────────────────────────────────────────────┐
│        CONSIDER DIFFERENTIAL DIAGNOSES              │
├─────────────────────────────────────────────────────┤
│  - RDS (preterm, ground-glass CXR, low volume)     │
│  - Sepsis/pneumonia (unwell, CRP↑, positive culture)│
│  - CHD (murmur, cardiomegaly, hypoxia)             │
│  - PPHN (severe hypoxia, pre-post sat difference)  │
│  - Pneumothorax (sudden deterioration, asymmetry)  │
│  - Meconium aspiration (meconium liquor, term)     │
└─────────────────────────────────────────────────────┘
                        ↓
┌─────────────────────────────────────────────────────┐
│     IF TTN LIKELY (Term, Post C-Section, Wet CXR)  │
│                                                     │
│  SUPPORTIVE RESPIRATORY CARE:                       │
│  ✓ Oxygen: titrate to SpO2 92-95% [1,13]          │
│    - Start with low-flow nasal cannulae (0.5-1 L/min)│
│    - Escalate to headbox if FiO2 more than 0.3     │
│  ✓ CPAP if moderate-severe (see below) [11,14]    │
│  ✓ Monitor work of breathing continuously          │
│                                                     │
│  FEEDING MANAGEMENT:                                │
│  ✓ Nil by mouth if RR more than 60/min [1]        │
│  ✓ IV fluids: 60-80 mL/kg/day (D10W)              │
│    - GIR 4-6 mg/kg/min                             │
│    - Avoid fluid overload (worsens lung oedema)    │
│  ✓ NG feeds when RR 60-80 and stable              │
│  ✓ Breast/bottle when RR consistently less than 60         │
│                                                     │
│  EMPIRICAL ANTIBIOTICS: [13,21]                     │
│  ✓ Benzylpenicillin 50 mg/kg IV q12h (less than 7 days)   │
│  ✓ Gentamicin 5 mg/kg IV q36h (adjust per levels) │
│  ✓ Continue until cultures negative at 36-48h     │
│  ✓ Stop if clinically well and CRP less than 5 at 24h     │
│                                                     │
│  AVOID:                                             │
│  ✗ Diuretics (no evidence; may worsen fluid balance)│
│  ✗ Salbutamol (no benefit; see evidence below) [5,14]│
│  ✗ Surfactant (not indicated in isolated TTN) [13]│
│  ✗ Routine intubation (escalate only if failing)  │
└─────────────────────────────────────────────────────┘
                        ↓
┌─────────────────────────────────────────────────────┐
│        EXPECTED COURSE                              │
│  - Peak symptoms: 12-24 hours                       │
│  - Improvement: 24-48 hours (↓RR, ↓O2 requirement) │
│  - Resolution: by 72 hours                          │
│  - If NOT improving by 24-48h → REASSESS diagnosis │
│    (Consider: RDS, CHD, PPHN, persistent infection)│
└─────────────────────────────────────────────────────┘
                        ↓
┌─────────────────────────────────────────────────────┐
│        DISCHARGE CRITERIA                           │
│  ✓ RR consistently less than 60/min in air        │
│  ✓ SpO2 more than 94% in air (sustained)          │
│  ✓ Feeding well (breast or bottle, 150 mL/kg/day) │
│  ✓ Weight stable or increasing                     │
│  ✓ Temperature stable (36.5-37.5°C)                │
│  ✓ Blood cultures negative at 36-48h              │
│  ✓ Antibiotics stopped                             │
│  ✓ Parents confident in feeding and monitoring     │
└─────────────────────────────────────────────────────┘

Supportive Respiratory Care

Clinical Pearl: CPAP in TTN - When and Why? [6,11,14]

Indications for CPAP:

• FiO2 requirement more than 0.4 despite low-flow oxygen [14]
• Silverman-Andersen score ≥7 (severe distress)
• pCO2 more than 60 mmHg with pH less than 7.25 (respiratory failure)
• Increasing work of breathing despite oxygen

Mechanism of Benefit:

• Recruits atelectatic alveoli (trapped behind fluid)
• Increases functional residual capacity (FRC)
• Reduces work of breathing by "splinting" airways open
• Improves V/Q matching

Cochrane Evidence (Moresco 2020): [6,14]

• CPAP reduces duration of tachypnoea by mean 8 hours (95% CI: -13.6 to -2.4 hours)
• CPAP reduces duration of supplemental oxygen by 18 hours
• CPAP reduces need for mechanical ventilation (RR 0.21, 95% CI 0.05-0.79)
• No increase in adverse events (pneumothorax, nosocomial infection)

Clinical Application:

• Start CPAP early if moderate-severe TTN (don't wait for failure)
• Use 5-6 cmH2O pressure (higher pressures may cause pneumothorax)
• Wean CPAP as work of breathing improves (usually within 12-24 hours)
• CPAP does NOT shorten total hospital stay but improves comfort and reduces escalation [14]

Nutrition and Feeding Management

IV Fluid Regimen (if nil by mouth):

• Fluid: 10% Dextrose (D10W)
• Volume: 60-80 mL/kg/day on day 1 (increase to 120-150 by day 3-4)
• Glucose Infusion Rate (GIR): 4-6 mg/kg/min (prevents hypoglycaemia)
• Electrolytes: Add sodium/potassium from day 2 if still on IV fluids
• Monitor: Blood glucose 4-6 hourly until feeding established [1]

NG Feeding Protocol:

• Start when RR 60-80 and stable (not rising)
• Volume: 30-40 mL/kg/day initially, increase by 20-30 mL/kg/day
• Frequency: 2-3 hourly bolus feeds (expressed breast milk or formula)
• Monitor for feed intolerance: vomiting, abdominal distension, aspirates
• Transition to oral when RR consistently less than 60 for 6+ hours [1,13]

Exam Detail: Why "Nil by Mouth" at RR more than 60?

The "60/60 rule" is based on respiratory physiology:

• Normal newborn RR: 30-50/min
• At RR more than 60/min, infant cannot coordinate suck-swallow-breathe triphasic reflex
• Risk of aspiration increases significantly (especially with bottle feeding)
• Aspiration of milk into lungs worsens respiratory distress and can cause chemical pneumonitis
• NG feeding bypasses the suck-swallow phase but still requires coordinated swallow-breathe
• At RR more than 80, even NG feeds may be unsafe → IV fluids mandatory [1,13]

Fluid Balance Considerations:

• Avoid fluid overload (worsens interstitial lung oedema)
• Restrict to 60-80 mL/kg/day on day 1 (physiological weight loss 5-10% is normal)
• Monitor for hyponatraemia if excess free water given
• Insensible losses are higher in tachypnoeic infants (add 10-20 mL/kg/day if RR more than 80)

Antibiotic Therapy

Rationale: TTN is a diagnosis of exclusion. Neonatal sepsis presents identically (tachypnoea, distress, hypoxia) and is life-threatening. Empirical antibiotics are therefore standard of care until infection excluded. [1,13,21]

Alternative Regimen (Some UK Units):

• Amoxicillin 50 mg/kg IV q12h + Gentamicin 5 mg/kg IV q36h
• Equivalent cover; amoxicillin preferred in some guidelines

Monitoring:

• Gentamicin levels: Pre-dose (trough) before 2nd or 3rd dose (target less than 2 mg/L)
• Renal function: Creatinine at 48-72 hours (gentamicin is nephrotoxic)
• CRP: Repeat at 24 hours (most sensitive time point for infection) [13,21]
• Blood cultures: Check at 36-48 hours (should be negative in TTN)

Decision to Stop Antibiotics: [13,21]

Exam Detail: NICE NG195 Guideline (2021) - Antibiotic Duration: [21]

Key Recommendation:

• If clinical condition improving AND blood cultures negative at 36 hours → STOP antibiotics
• This applies to suspected early-onset sepsis (which includes TTN in differential)
• Rationale: Reduces antibiotic exposure, hospital stay, disruption to microbiome, and antimicrobial resistance

Clinical Application in TTN:

• Day 0 (admission): Start benzylpenicillin + gentamicin after blood culture taken
• Day 1 (24 hours): Check CRP (repeat from admission)
  • If CRP less than 5 mg/L + improving clinically → plan to stop at 36-48h
  • If CRP more than 10 mg/L → continue antibiotics (likely infection, not pure TTN)
• Day 2 (36-48 hours): Check blood culture result
  • If negative + clinical improvement → STOP antibiotics
  • If positive → continue 7-14 days per organism and sensitivities

Common Exam Mistake:

• Candidates often say "continue antibiotics for 5-7 days" in TTN
• Correct answer: Stop at 36-48 hours if cultures negative and improving [13,21]
• Continuing antibiotics unnecessarily is poor practice (NICE guidance)

Interventions NOT Recommended (Evidence-Based)

Clinical Pearl: Why Doesn't Salbutamol Work in TTN? [5,14]

Theoretical Rationale:

• β2-agonists (salbutamol) stimulate β-adrenergic receptors
• β-adrenergic activation increases ENaC expression (similar to catecholamines)
• Therefore, salbutamol should enhance lung fluid clearance

Actual Evidence - Cochrane Review (Moresco 2021): [5,14]

• 7 RCTs, 660 infants
• Salbutamol (nebulised or IV) vs placebo
• No reduction in:
  • Duration of tachypnoea (MD 0.23 hours, 95% CI -3.2 to 3.7)
  • Duration of oxygen requirement (MD -2.9 hours, 95% CI -10.6 to 4.8)
  • Hospital length of stay (MD -0.5 days, 95% CI -1.4 to 0.3)
  • Need for CPAP or mechanical ventilation
• No difference in adverse events (tachycardia, tremor)

Conclusion: Salbutamol does NOT work in TTN despite theoretical rationale [5,14]

Why the Discrepancy?

• Postnatal ENaC expression is already maximal by 6-12 hours
• Additional β-agonist stimulation does not further increase absorption
• Fluid clearance is rate-limited by lymphatic drainage, not ENaC activity alone
• Salbutamol may cause tachycardia (confounds assessment of tachypnoea)

Clinical Implication:

• Do NOT use salbutamol for TTN (Cochrane evidence; high quality) [5,14]
• Common exam trap: "Would you give salbutamol?" Answer: No, no evidence of benefit

Escalation Criteria

Exam Detail: Viva Question: "When Would You Intubate a Baby with TTN?"

Model Answer: "Intubation is very rarely needed in isolated TTN - it occurs in less than 1% of cases. I would consider intubation if:

1. Respiratory failure despite CPAP: FiO2 more than 0.6 on CPAP 6 cmH2O, or pCO2 more than 65 with pH less than 7.20
2. Apnoea or bradycardia: Indicating impending respiratory arrest
3. Severe metabolic acidosis: Suggesting shock or sepsis rather than pure TTN
4. Pneumothorax not responding to chest drain: Tension physiology

However, if a baby requires intubation, I would seriously reconsider the diagnosis of TTN. It is more likely to be RDS requiring surfactant, severe pneumonia, PPHN, or congenital heart disease. I would discuss with senior colleagues and consider echocardiography and potentially surfactant therapy."

Examiner Follow-Up: "What Ventilation Strategy Would You Use?"

"I would use lung-protective ventilation:

• Mode: Pressure-controlled or SIMV
• PIP: 18-22 cmH2O (start low, titrate to chest rise)
• PEEP: 5-6 cmH2O (maintain FRC)
• Rate: 40-60/min
• Inspiratory time: 0.3-0.4 seconds
• FiO2: Titrate to SpO2 92-95%
• Target: pH more than 7.25, pCO2 45-55 mmHg (permissive hypercapnia acceptable)

If minimal improvement within 6-12 hours, I would give surfactant (as likely RDS misdiagnosed as TTN) and reassess for other causes." [1,13]

---

8. Complications

Complications of TTN

Long-Term Outcomes

---

9. Prognosis and Outcomes

Natural History

Clinical Pearl: Predicting Time to Resolution:

Favourable Prognostic Factors (Likely to Resolve less than 48 hours):

• Term infant (39-40 weeks) - earlier ENaC maturation [1,17]
• Mild symptoms at presentation (Silverman-Andersen score less than 4)
• FiO2 requirement less than 0.3 - indicates mild V/Q mismatch
• Rapid improvement in first 12 hours (RR decreasing by more than 20%)
• Normal or mildly elevated CRP (less than 5 mg/L) - excludes infection [13]

Adverse Prognostic Factors (May Take 48-72+ hours):

• Late preterm (34-36 weeks) - immature ENaC expression [17]
• Moderate-severe symptoms (Silverman-Andersen ≥7, FiO2 more than 0.4)
• Maternal diabetes - delayed lung maturation [1,7]
• Small pleural effusions on CXR - more fluid to clear [3]
• Male sex - males have higher respiratory morbidity overall [1,7]

Red Flags - Reconsider Diagnosis if:

• No improvement by 24 hours (static RR, oxygen requirement)
• Worsening after initial stabilisation - think pneumothorax, evolving sepsis, PPHN
• Symptoms persisting more than 72 hours - investigate for CHD, RDS, infection [1,13]

Prognostic Factors

Short-Term Outcomes

Long-Term Respiratory Outcomes

Emerging Evidence - Controversy Regarding Childhood Asthma: [12,19]

Current Understanding (2025): [12,19]

Key Findings from Pollak et al. (2025): [12]

• Large Israeli cohort: 8,456 children, 15-year follow-up
• TTN diagnosis associated with increased risk of preschool asthma (age 2-5 years)
  • Adjusted OR 1.4 (95% CI 1.2-1.7) after controlling for gestational age, mode of delivery
• Effect attenuates by school age (OR 1.2, 95% CI 0.9-1.5 at age 6-10 years)
• Mechanism unclear: genetic susceptibility? airway inflammation? altered microbiome?

Clinical Interpretation:

• Association does NOT prove causation [12,19]
• Confounding factors: C-section delivery (alters gut/lung microbiome), maternal asthma, genetic predisposition
• Most children with TTN do NOT develop asthma (absolute risk increase less than 5%)
• Insufficient evidence to recommend routine respiratory follow-up solely based on TTN history [12,19]

Guideline Recommendation:

• No routine respiratory follow-up after TTN unless other risk factors (family history, recurrent wheeze)
• Educate parents about normal respiratory infections in first 2 years
• If recurrent wheeze develops (≥3 episodes), assess as per standard asthma guidelines [12]

Exam Detail: Viva Question: "Does TTN Cause Long-Term Respiratory Problems?"

Model Answer: "The vast majority of infants with TTN make a complete recovery with no long-term respiratory sequelae. [1,2,13]

However, there is emerging epidemiological evidence suggesting a possible association between TTN and preschool asthma:

• Pollak et al. (2025) found a modest increased risk of asthma at age 2-5 years (OR 1.4) in children who had TTN [12]
• The effect appears to attenuate by school age
• However, this is an association, not causation
• Confounding factors include mode of delivery (C-section independently increases asthma risk), maternal atopy, and genetic susceptibility
• The absolute risk increase is small (less than 5%)

Clinical Practice:

• I would reassure parents that TTN itself does not cause long-term lung damage
• I would not recommend routine respiratory follow-up based solely on TTN history
• I would advise parents to watch for signs of recurrent wheeze (≥3 episodes), which would warrant asthma assessment as per standard guidelines
• If the child has additional risk factors (parental asthma, eczema, allergies), I would have a lower threshold for asthma assessment [12,19]"

Examiner Follow-Up: "Would You Recommend Avoiding C-Section to Prevent TTN?"

Model Answer: "The decision regarding mode of delivery should be based on maternal and fetal indications, not solely to avoid TTN. [7,13]

Key Points:

• Elective C-section does increase TTN risk (RR 3-4), but TTN is self-limiting and benign [2,7]
• More important is timing of elective C-section: RCOG and ACOG recommend ≥39 weeks to minimise respiratory morbidity [7,13]
• At 37-38 weeks, respiratory morbidity (including TTN and RDS) is 3-4 times higher than ≥39 weeks [7]
• Antenatal corticosteroids (betamethasone) reduce respiratory morbidity in planned C-section at 37-38 weeks (ALPS trial - NEJM 2016) [4]

Counselling:

• If maternal choice for elective C-section, I would recommend waiting until 39+ weeks [7,13]
• If medical indication for delivery at 37-38 weeks, I would discuss antenatal steroids (reduces TTN and RDS by 50%) [4,7]
• I would explain that TTN, while requiring NICU admission, has excellent prognosis with no long-term harm [1,2,13]" [4,7,13]

Outcomes Data - Summary Table

---

11. Evidence and Guidelines

Clinical Practice Guidelines

Landmark Studies and Systematic Reviews

Pathophysiology and Aetiology:

Epidemiology and Risk Factors:

Diagnosis and Imaging:

Management - Cochrane Systematic Reviews:

Prevention:

Long-Term Outcomes:

Evidence Summary Table

Quality of Evidence Assessment (GRADE)

---

10. Prevention Strategies

Primary Prevention

Goal: Reduce incidence of TTN through evidence-based obstetric practices. [4,7,13]

Exam Detail: 1. Timing of Elective Caesarean Section - Key Evidence [7,13]

Hansen et al. (2008) - Landmark Danish Cohort: [7]

• N = 34,458 planned deliveries
• Respiratory morbidity (TTN + RDS + oxygen requirement) by gestational age:
  • "37 weeks: 9.6% (95% CI 8.1-11.1%)"
  • "38 weeks: 5.0% (95% CI 4.4-5.7%)"
  • "39 weeks: 2.1% (95% CI 1.8-2.4%)"
  • "40+ weeks: 1.2% (95% CI 0.9-1.5%)"
• Relative Risk of respiratory morbidity:
  • 37 weeks vs 39+ weeks: RR 8.0 (95% CI 6.2-10.3)
  • 38 weeks vs 39+ weeks: RR 4.2 (95% CI 3.4-5.1)
• Conclusion: Each additional week from 37-40 weeks reduces respiratory morbidity by 50%

RCOG Guideline (Green-top 2022): [13]

• Recommendation: Elective C-section should not be performed before 39+0 weeks unless medical indication
• Rationale: Minimise neonatal respiratory morbidity (TTN, RDS, NICU admission)
• Exception: If delivery required at 37-38 weeks for medical reasons → offer antenatal corticosteroids [4,13]

ACOG (American College) Guideline: [7]

• Similar recommendation: ≥39 weeks for elective C-section
• Emphasises shared decision-making with patient counselling

Clinical Application:

• If mother requests elective C-section at 38 weeks: counsel regarding 4-fold increased respiratory morbidity
• If medical indication for 37-38 week delivery: offer betamethasone (reduces risk by 50%) [4]
• If no indication for early delivery: schedule at 39+0 to 39+6 weeks [7,13]

2. Antenatal Corticosteroids - ALPS Trial (NEJM 2016) [4]

Study Design:

• Multicentre RCT, N = 2,831 women
• Population: Planned C-section at 37-38+6 weeks (late preterm and early term)
• Intervention: Betamethasone 12 mg IM × 2 doses (24 hours apart) vs placebo
• Primary Outcome: Neonatal respiratory complications (TTN, RDS, CPAP, mechanical ventilation, oxygen for more than 2 hours)

Results:

• Respiratory complications:
  • "Betamethasone group: 11.6%"
  • "Placebo group: 14.4%"
  • RR 0.80 (95% CI 0.66-0.97), p = 0.02
  • NNT = 20 (treat 20 mothers to prevent 1 case of respiratory morbidity)
• Subgroup Analysis:
  • "Effect strongest at 37 weeks: RR 0.60 (NNT = 12)"
  • "Effect attenuated at 38 weeks: RR 0.85 (NNT = 30)"
• No increase in adverse maternal or fetal outcomes

Limitations:

• Slight increase in neonatal hypoglycaemia in steroid group (24% vs 15%, pless than 0.001)
  • Requires blood glucose monitoring (already standard in at-risk newborns)
• Long-term neurodevelopmental outcomes unknown (theoretical concern about multiple steroid courses)

ACOG Recommendation (2016 Updated): [4]

• Consider antenatal corticosteroids for planned C-section at 37-38+6 weeks
• Individualise decision (maternal preference, hypoglycaemia risk, feasibility)
• Do NOT use if:
  • Planned delivery ≥39 weeks (no benefit, potential harm from hypoglycaemia)
  • Multiple prior steroid courses (unknown safety)
  • Maternal diabetes (already high hypoglycaemia risk)

Clinical Application in Exam:

• If asked: "Mother needs C-section at 37 weeks for placenta praevia. What would you recommend?"
• Answer: "I would offer antenatal betamethasone based on ALPS trial evidence (NNT 20 to prevent respiratory complications). I would counsel regarding small increased risk of neonatal hypoglycaemia requiring monitoring." [4]

3. Labour as Protective Factor [1,2,7,10]

Mechanism:

• Labour (even without vaginal delivery) triggers:
  • Massive catecholamine surge (10-20× baseline) [1,10]
  • Endogenous glucocorticoid release (cortisol increases 2-3×) [10]
  • Uterine contractions → intermittent thoracic compression
• Result: ENaC activation, fluid absorption, lung fluid clearance [1,10,17]

Evidence:

• Emergency C-section (after labour) has 40-60% lower TTN risk than elective C-section (no labour) [2,7]
• Even short labour (2-4 hours) provides partial protection [2]

Practical Challenge:

• Allowing spontaneous labour in planned C-section is impractical (unpredictable timing, emergency setting)
• Some units offer "trial of labour" if low-risk indication (e.g., maternal request C-section)
• Not standard practice; weak recommendation [7]

Secondary Prevention (Early Detection)

Tertiary Prevention (Preventing Complications)

---

---

11. Patient Explanation

Explanation for Parents

What is transient tachypnoea of the newborn (TTN)? TTN is a common breathing problem in newborn babies. It happens when there is extra fluid left in your baby's lungs after birth. Normally, this fluid drains away quickly, but in some babies (especially after caesarean section), it takes a bit longer.

What causes it? Before birth, your baby's lungs are filled with fluid. During vaginal delivery, pressure on the chest and hormones released during labour help squeeze this fluid out. After a caesarean section, especially if there was no labour, this fluid takes longer to clear.

Is it serious? TTN is not usually serious. Most babies recover completely within 24 to 72 hours without any long-term problems. However, we need to make sure it is not a more serious infection, so we will do some tests.

What symptoms will my baby have?

• Fast breathing (more than 60 breaths per minute)
• Ribs showing with each breath (recession)
• Grunting sounds
• Sometimes needing extra oxygen

What tests will be done?

• A chest X-ray to look at your baby's lungs
• Blood tests to check for infection
• Monitoring oxygen levels with a sensor on the hand or foot

How is it treated?

• Oxygen: We may give extra oxygen through small tubes in the nose
• Feeding: If your baby is breathing too fast (more than 60 breaths/min), we will give milk through a tube into the stomach because fast breathing can cause choking
• Antibiotics: We may start antibiotics just in case there is an infection. These can be stopped after 36-48 hours if the blood tests are clear
• Monitoring: We will watch your baby closely until breathing settles

Will my baby be okay? Yes. Almost all babies with TTN make a complete recovery. You should be able to take your baby home once they are feeding well and breathing normally.

---

12. References

1. Alhassen Z, Vali P, Guglani L, et al. Recent Advances in Pathophysiology and Management of Transient Tachypnea of Newborn. J Perinatol. 2021;41(1):6-16. doi:10.1038/s41372-020-0757-3. PMID: 32753712

2. Edwards MO, Kotecha SJ, Kotecha S. Respiratory distress of the term newborn infant. Paediatr Respir Rev. 2013;14(1):29-36. doi:10.1016/j.prrv.2012.02.002. PMID: 23347658

3. Liu J, Cao HY, Wang HW, Kong XY. The role of lung ultrasound in diagnosis of respiratory distress syndrome in newborn infants. Iran J Pediatr. 2015;25(1):e323. doi:10.5812/ijp.323

4. Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311-1320. doi:10.1056/NEJMoa1516783. PMID: 26842679

5. Moresco L, Bruschettini M, Macchi M, et al. Salbutamol for transient tachypnea of the newborn. Cochrane Database Syst Rev. 2021;2(2):CD011878. doi:10.1002/14651858.CD011878.pub3. PMID: 33543473

6. Moresco L, Romantsik O, Calevo MG, et al. Non-invasive respiratory support for the management of transient tachypnea of the newborn. Cochrane Database Syst Rev. 2020;4(4):CD013231. doi:10.1002/14651858.CD013231.pub2. PMID: 32302428

7. Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ. 2008;336(7635):85-87. doi:10.1136/bmj.39405.539282.BE. PMID: 18077437

8. Lovrenski J, Raissaki M, Plut D, et al. ESR Essentials: imaging of common paediatric pulmonary diseases-practice recommendations by the European Society of Paediatric Radiology. Eur Radiol. 2025;35(8):5037-5052. doi:10.1007/s00330-024-11268-4. PMID: 39881039

9. Ma HR, Liu J, Yan WK. Accuracy and Reliability of Lung Ultrasound to Diagnose Transient Tachypnoea of the Newborn: Evidence from a Meta-analysis and Systematic Review. Am J Perinatol. 2022;39(9):973-979. doi:10.1055/s-0040-1721134. PMID: 33242910

10. Helve O, Pitkänen O, Janér C, et al. Pulmonary fluid balance in the human newborn infant. Neonatology. 2009;95(4):347-352. doi:10.1159/000209300. PMID: 19494556

11. Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol. 2006;30(1):34-43. doi:10.1053/j.semperi.2006.01.006. PMID: 16549212

12. Pollak M, Shapira M, Gatt D, et al. Transient Tachypnea of the Newborn and the Association with Preschool Asthma. Ann Am Thorac Soc. 2025;22(6):881-886. doi:10.1513/AnnalsATS.202408-873OC. PMID: 40382764

13. Bruschettini M, Hassan KO, Romantsik O, et al. Interventions for the management of transient tachypnoea of the newborn - an overview of systematic reviews. Cochrane Database Syst Rev. 2022;2(2):CD013563. doi:10.1002/14651858.CD013563.pub2. PMID: 35199848

14. Hermansen CL, Lorah KN. Respiratory Distress in the Newborn. Am Fam Physician. 2007;76(7):987-994. PMID: 17956068

15. Liu J, Cao HY, Fu W. Lung Ultrasonography to Diagnose Transient Tachypnea of the Newborn. Chest. 2016;149(5):1269-1275. doi:10.1016/j.chest.2015.12.024. PMID: 26836942

16. Li CS, Zhang WB, Wang ZQ, et al. Prospective investigation of serial ultrasound for transient tachypnea of the newborn. Pediatr Neonatol. 2021;62(1):62-68. doi:10.1016/j.pedneo.2020.09.007. PMID: 32972849

17. Yurdakök M. Transient tachypnea of the newborn: what is new? J Matern Fetal Neonatal Med. 2010;23 Suppl 3:24-26. doi:10.3109/14767058.2010.507971. PMID: 20807157

18. Castorena-Torres F, Mendoza-Durán JC, Montoya-Contreras A, et al. Aquaporine-5 and epithelial sodium channel β-subunit gene expression in gastric aspirates in human term newborns with transient tachypnea. Heliyon. 2018;4(6):e00664. doi:10.1016/j.heliyon.2018.e00664. PMID: 29862364

19. Risnes KR, Belanger K, Murk W, Bracken MB. Antibiotic exposure by 6 months and asthma and allergy at 6 years: Findings in a cohort of 1,401 US children. Am J Epidemiol. 2011;173(3):310-318. doi:10.1093/aje/kwq400. PMID: 21190986

20. Jiang P, Liu Y, Zhu L, et al. Lung ultrasound to evaluate the outcome and prognosis of transient tachypnea of the newborn. Front Pediatr. 2024;12:1448086. doi:10.3389/fped.2024.1448086. PMID: 39895991

21. National Institute for Health and Care Excellence. Neonatal infection: antibiotics for prevention and treatment. NICE guideline [NG195]. Published April 2021. Updated August 2024. https://www.nice.org.uk/guidance/ng195

22. Tutdibi E, Gries K, Bücheler M, Misselwitz B, Schlosser RL, Gortner L. Impact of labor on outcomes in transient tachypnea of the newborn: population-based study. Pediatrics. 2010;125(3):e577-e583. doi:10.1542/peds.2009-0314. PMID: 20156897

---

---

13. Examination Focus

Common Exam Questions

High-Yield Viva Points

CXR Comparison Table (Exam Favourite)

Common Mistakes

Examination Cheat Sheet